Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Taste receptor type 2 member 20 (TAS2R20) is a member of the bitter taste receptor family, which belongs to the G protein-coupled receptor (GPCR) superfamily. TAS2Rs, including TAS2R20, mediate the detection of diverse bitter compounds in the oral cavity and provide an evolutionary advantage by warning the organism against ingestion of potentially harmful substances, as many toxins taste bitter. The TAS2R gene family comprises around 25 genes in humans; each receptor exhibits a unique but sometimes overlapping spectrum of ligand sensitivity. They function via a single orthosteric binding pocket, which can accommodate structurally diverse bitter agonists. TAS2R20 is expressed in taste-bud cells of the tongue and, like other taste receptors, signals through G proteins, particularly gustducin, to trigger neuronal responses that result in bitter taste perception. Although highly variable at the genetic and functional levels, there is no currently confirmed direct disease role or approved therapeutic targeting for TAS2R20 itself[1][2].
For agonists: Activation of TAS2R20 by bitter compounds leads to G protein-mediated intracellular signaling (involving gustducin and subsequent signal cascades), resulting in perception of bitter taste[1][2]. No antagonists or other drug-based mechanisms of action are reported in current literature for TAS2R20.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Taste receptor type 2 member 20 (TAS2R20).